Experts Address Consumer Contact Lens Online Search Habits
Ortho-K Offers Significant Advantages Beyond Myopia Control, According to New Publication
TECH5 Introduces its Biometric Derived Keys Technology for Identity Management
Avalue Medical-Grade Touch Panel PC HID-1337.. Driving Full Integration in Next-Generation Digital Healthcare Platform
Purchase Factors Drive Online Contact Lens Searches (New U.S. & Canadian Research)
Avalue Unveils Cutting-Edge AI-Driven Healthcare Solutions at HIMSS Global Health Exhibition in the U.S
Avalue to exhibit at Arab Health 2025, driving the digital transformation of healthcare
CORE Publishes “The Science of Myopia Control: What Every ECP Should Know”
Three New Peer Reviewed Papers Expand Myopia Management Evidence for Diffusion Optics Technology
Centre for Eye and Vision Research (CEVR) and SCOPE Health to Partner for Dry Eye Tech
-
DKSH and FrontierView Publish Whitepaper on Southeast Asia as a Growth Accelerator for Global Healthcare Firms
DKSH, a leading market expansion service provider in Asia and beyond, in collaboration with FrontierView, released the whitepaper “Southeast Asia as a Growth Accelerator for Global Healthcare Firms: Avenues to accelerate growth through expanded patient access.” The whitepaper, a result of a closed-door executive roundtable encompassing key leaders within the healthcare arena, provides an in-depth analysis on the region of Southeast Asia (SEA) as an untapped market that has yet to reach its full potential on the front of global healthcare investment. It provides an overview of the state of healthcare in the region, its foreseeable future, the challenges present and actionable recommendations for global healthcare firms to consider. As a region, SEA is home to approximately 8.5% of the world’s population, but has a healthcare expenditure that amounts to only 1.4% of the global total. This disproportionate scale is poised for positive change with an increased importance placed on healthcare in recent years following the COVID-19 pandemic. This coincides with a booming population and a sizable forecasted rise in overall wealth in the region – setting the stage for a unique backdrop for the healthcare industry. Cognisant of this prospect, FrontierView extensively reviewed SEA’s healthcare landscape with the support of DKSH, revealing numerous challenges endemic to the region. Though geographically limited, SEA is home to 11 countries, each with their own set of socio-economic difficulties that the whitepaper collated and analyzed. This highlighted very tangible hurdles for healthcare firms looking to enter the region, including localization and navigating multiple regulatory bodies. This is all encompassed by the overarching dominance held by public healthcare systems across the region, which has been largely characterized by their struggles related to budgetary and manpower constraints. Challenges revealed in the whitepaper also highlighted opportunities for global firms to increase healthcare accessibility in SEA. The constraints of public healthcare systems in the region have led to more active exploration of the private sector in order to fill the gaps. Shortfalls in the public sector have been addressed through solutions such as public-private partnerships which increase capability, efficacy and accessibility in the region without compromising government resources. The whitepaper also includes a series of recommendations backed by extensive analysis for global healthcare firms interested to enter the market. This includes forming strategies around addressing the personnel shortage, applying advanced technologies like AI to tackle unique local issues and supporting early detection as well as prevention. These recommendations and more elaborated in the whitepaper serve as an accessible and actionable guide for the private sector looking to enter this region brimming with latent opportunity. “At DKSH, we are dedicated to improving lives by increasing accessibility to healthcare across the region. We are conscious of the complexities involved in expanding healthcare efforts, especially when penetrating new geographies. With a century of experience as the partner of choice for navigating and thriving in Asia, DKSH has accumulated a wealth of knowledge. We are excited that we were able to share our expertise and support this whitepaper which will equip our partners with the latest insights and strategies to succeed in Southeast Asia.”, said Bijay Singh, Head of Business Unit Healthcare at DKSH. Alec Lee, Managing Director, Healthcare Research at FrontierView said that “Southeast Asia’s healthcare market is a fascinating topic and one that greatly benefits from continued in-depth analysis”. He added that “in addition to the data from our research, this whitepaper incorporates insights from leading healthcare companies, including DKSH, gathered during our executive roundtable. As a result, this has proven to be an exciting step in uncovering the full potential latent in this region. We hope that the actions outlined in the whitepaper will contribute to improving healthcare access.”
-
World Council of Optometry and Alcon Launch “WCO Alcon Dry Eye Wheel” Tool in Spanish
The World Council of Optometry (WCO) and Alcon Dry Eye Wheel, a practical tool that helps with the diagnosis and treatment of dry eye disease, is now available in Spanish. Developed by world-renowned educators Professors Jennifer Craig, Lyndon Jones, and James Wolffsohn, the wheel is an at-a-glance, interactive tool designed to easily reference the three pillars of mitigation, measurement, and management. It is accessible to the Spanish-speaking optometry community at no cost via the WCO website at https://dryeye.worldcouncilofoptometry.info/interactive-dry-eye-wheel/ WCO and Alcon initially partnered to develop the dry eye disease education initiative to raise optometrists’ understanding of dry eye and deliver resources on practical management. Dry eye disease can be a chronic, painful condition. About 1.4 billion people are affected by dry eye symptoms worldwide,1 with reports of increased occurrence aligning with notable factors such as increasing use of technology, environmental triggers, and an aging population.2 The education initiative brings together experts to share the latest dry eye disease data and science with clinical and academic colleagues. With 41% of people in Mexico and 13% of people who live in Brazil suffering from dry eye,3 continued education and resources directed specifically toward Latin American countries are much needed. The availability of the Spanish wheel complements the recent publication of Latin American Consensus on Ocular Lubricants and Dry Eye (LUBOS) in Oftalmología Clínica y Experimental, the scientific journal of the Argentinian Council of Ophthalmology. The work aims to create a diagnostic and therapeutic algorithm for dry eye, focused on the proper use of lubricants. “It was imperative that the wheel be available in Spanish, since it’s one of the most widely spoken languages in the world,” said Dr. Sandra S. Block, O.D., M.Ed., MPH, FAAO, FCOVD, president of the World Council of Optometry. “This latest development affirms WCO’s continued commitment to education around the diagnosis and treatment of dry eye disease. We are grateful to Alcon for their continued partnership in the fight against this global epidemic.” The wheel’s Spanish translation was provided in collaboration with Colegio Federación Colombiana de Optómetras – Fedopto. To use the Dry Eye Wheel in Spanish and discover other dry eye disease resources on the WCO website, visit: https://dryeye.worldcouncilofoptometry.info/interactive-dry-eye-wheel/
-
CORE Publication on Multifocal Contact Lenses Builds Fitting Confidence and Aids Wearer Adoption
Although an increasing number of multifocal contact lens options are available, global prescribing rates remain relatively low, primarily due to perceived fitting challenges in the category. The Centre for Ocular Research & Education (CORE) has focused Issue 80 of Contact Lens Update on providing insights and tips for eye care practitioners to build greater confidence in recommending multifocal lenses and to aid successful wearer adoption. The bi-monthly publication is available at no charge by visiting ContactLensUpdate.com "Multifocal soft contact lenses have been available for decades; however, their penetration into the market remains low, despite more advanced products being introduced over that time. These lenses are available in a wide range of powers, including astigmatic corrections, and in various materials. They also come in different replacement schedules, including daily disposable options,” said Jill Woods, Head of Clinical Research at CORE. “These innovations present an opportunity to fit more of the presbyopic population than ever before, yet many patients are unaware of the possibility. Contact Lens Update Issue 80 is designed to help overcome the profession’s cautiousness—rooted in legacy concerns about fitting time and a fear of failure—by presenting new research that can be directly translated into better patient care and satisfaction.” James S. Wolffsohn, Professor of Optometry and the Head of the School of Optometry at Aston University, writes the issue’s opening editorial. He presents a comprehensive overview of the BCLA CLEAR (Continued Learning Evidence-based Academic Reports) presbyopia initiative, providing an update on current knowledge and management of the condition. Jill Woods is a global expert on presbyopia, myopia control, dry eye, and contact lens performance. With nearly 20 years of experience in presbyopia research and numerous publications in the field, she provides the feature article that examines how patients' initial reactions to soft multifocal contact lenses can predict overall vision satisfaction and intention to purchase after one week of wear, which can be a strong indicator of success. Doerte Luensmann, a Senior Clinical Scientist at CORE, contributes her expertise in clinical trial management for multisite global and domestic studies, assisting in study design and site management. Her clinical insight infographic offers a proactive guide for optimizing multifocal soft contact lens fitting, including determining full refraction and ocular dominance and ensuring patient satisfaction with follow-up communication and training. The conference highlight is shared by Sabyasachi Goswami, a graduate student in Brain & Cognitive Sciences at the University of Rochester, who specializes in visual neuroscience with research interests in myopia, accommodation, and optical limitations of human vision. The study examines how various refractive zonal designs in multifocal contact lenses affect visual quality, including acuity, contrast sensitivity, and preference, using adaptive optics to suggest possible patient-specific customization. In addition to a complete archive of back issues, ContactLensUpdate.com offers a resource library that provides no-cost professional tools, patient resources, images and video. It also houses complimentary technical training videos produced by International Association of Contact Lens Educators, plus an industry glossary. Industry professionals can access the latest issue directly from ContactLensUpdate.com or quickly sign up for email receipt of future issues. The publication receives support from the educational arms of CooperVision and Johnson & Johnson Vision.
-
Expert Panel Discusses How to Reduce Contact Lens Dropout
A recording of the “Disrupting the Dropout Dilemma: Bold Moves to Keep Patients in Contact Lenses” panel from Vision Expo West 2024 is now available for viewing at https://youtu.be/oKiCJ9osn-E. Presented on the Innovation Stage in Las Vegas, the 30-minute discussion previews new Contact Lens Institute consumer research that points to straightforward, high-return actions by eye care practices have the potential to increase retention rates among new and long-term contact lens wearers. Panelists include Jennifer Seymour Brusven, LDO, NCLE-AC, ABO-AC, Yesnick Vision Center; Janelle Davison, OD, Brilliant Eyes Vision Center; and Shalu Pal, OD, FAAO, FSLS, FBCLA, FIAOMC, Dr. Shalu Pal & Associates. Contact Lens Institute Chairperson Carla Mack, OD, FAAO, Dipl AAO, FBCLA, moderates the conversation. The research was commissioned by the Contact Lens Institute and conducted by Prodege from August 9-21, 2024, via an online survey. Respondents were U.S. residents ages 18-64 who reported wearing soft contact lenses at least once per week, inclusive of new wearers (n=200) and long-term wearers (n=201). A comprehensive report, part of the Contact Lens Institute’s See Tomorrow initiative, will be published in early November. The Contact Lens Institute advances the latest innovations in safe and effective contact lens and lens care products and services that provide unique benefits to patients while satisfying the evolving needs of eye care professionals. CLI undertakes activities that properly assess, enhance, promote, and balance contact lens and lens care industry welfare and growth, including the safe use of products in the marketplace. Its members include Alcon, Bausch + Lomb, CooperVision, and Johnson & Johnson Vision. For more information, visit contactlensinstitute.org
-
IMC 2024 News: Multiple Studies Reinforce SightGlass Vision DOT Efficacy for Myopia Management
Multiple studies presented this week at the 2024 International Myopia Conference (IMC) in China significantly reinforce the performance of SightGlass Vision’s Diffusion Optics Technology™ (DOT 0.2) spectacle lenses in slowing myopia progression in children1. The studies affirm positive performance in clinical and real-world settings, demonstrating excellent safety and efficacy, and the lack of a rebound effect. “The range and depth of evidence being shared at IMC—nine works on contrast theory and DOT lenses as well as an invited guest lecture on contrast theory—should further expand confidence in DOT spectacle lenses, our innovative approach to myopia control,”1,2 said Andrew Sedgwick, CEO of SightGlass Vision. CHINA and U.S. BASED Clinical Trials With IMC taking place in Hainan, of particular interest is the six-month data reporting from the CATHAY trial—a two-year, randomized, controlled study across five hospitals in China. Control of Myopia Using Diffusion Optics Technology (DOT) Spectacle Lenses in a Chinese Population: 6-Month Results (Chen Z, et al.) evaluates 186 participants after six months of wear, demonstrating that DOT lenses substantially slows myopia progression as evidenced by minimal change in axial length (AL) and cycloplegic refractive error compared to control group.1 A related analysis—Initial Axial Length Response to Diffusion Optics Technology (DOT) Spectacle Lens Wear (Laughton D, et al.)—shows that AL elongation is halted in almost half of the DOT lens group after six months of wear.3 Following completion of the four-year CYPRESS clinical study in the United States, 54 children were enrolled to assess if the treatment benefit was retained after discontinuing DOT lens wear. Myopia Progression After Cessation of Diffusion Optics Technology (DOT) Spectacle Lenses (Hill J, et al.) presents six-month interim results from the study, suggesting that neither refractive error nor AL increases are faster after DOT lens discontinuation compared to the control2. “Patterns of Ocular Growth in Young Children Wearing Diffusion Optics Technology (DOT) Spectacle Lenses: A 3-Year Longitudinal Study” shares the particularly positive outcomes for six- and seven-year-old patients in the CYPRESS clinical trial4. Real World Efficacy in China and Canada CLINICAL SETTINGS During IMC, SightGlass is making public two real world studies that further validate clinical trial results, using data from patients in China and Canada. Real-World Effectiveness of Diffusion Optics Technology (DOT) Spectacle Lenses for Myopia Control in Chinese Children (Wang L, McParland M) reviews clinical records from 147 DOT lens patient records. Results show that changes in both refractive error and axial length at six and 12 months from baseline are not significant.5 One-Year Myopia Control Performance of Contrast Modulation Spectacle Lenses Compared to Defocus-Based Spectacle Lenses in a Canadian Practice (Ho K, et al.) analyzes the efficacy of DOT spectacle lenses and peripheral defocus spectacle lenses in 80 Asian-Canadian children ages six to eight at treatment initiation. The study indicates that DOT lenses are more effective in slowing myopia progression (45% better as measured by mSER) compared to the other myopia control lens.6 FOUNDATIONAL RESEARCH SightGlass Vision’s commitment to building scientific understanding surrounding myopia control will also be evident at the IMC, including posters on Subfoveal Choroidal Thickness Changes After 1-Week of Myopia Control Spectacle Lens Wear (Desiato A, et al.), Contrast Sensitivity Function Differentiates Between Myopia Control Spectacle Lens Designs with Glare and Luminance Manipulations (Wolffsohn J, et al.) and Why Does Near Work Cause Myopia and How Might We Intervene Optically? (Langan R). Myopia innovator, researcher, and University of Washington Professor Jay Neitz, PhD, has been invited to present on Contrast Theory and its Implications for Novel Myopia Interventions. SightGlass Vision’s patent-protected technology has made its commercial debut in several markets, including China, the Netherlands, and Israel, as well as through preliminary market trials in other countries. The company operates as a joint venture of CooperCompanies and EssilorLuxottica. For more information, visit SightGlassVision.com ### 1 Chen et al. Control of Myopia using Diffusion Optics Technology (DOT) spectacle lenses in a Chinese population: 6-month results. To be presented at International Myopia Conference 2024. 2 Hill et al. Myopia progression after cessation of Diffusion Optics Technology (DOT) spectacle lenses. To be presented at International Myopia Conference 2024. 3 Laughton et al. Initial axial length reduction in response to Diffusion Optics Technology (DOT) spectacle lens wear. To be presented at International Myopia Conference 2024. 4 Sheppard et al. Patterns of ocular growth in young children wearing Diffusion Optics Technology (DOT) spectacle lenses: a 3-year longitudinal study. To be presented at International Myopia Conference 2024. 5 Wang et al. Real-World Effectiveness of Diffusion Optics Technology (DOT) Spectacle Lenses for Myopia Control in Chinese Children. To be presented at International Myopia Conference 2024. 6 Ho et al. One-Year Myopia Control Performance of Contrast Modulation Spectacle Lenses Compared to Defocus-Based Spectacle Lenses in a Canadian Practice. To be presented at International Myopia Conference 2024.
-
CLI Research Pinpoints Actions to Reduce Contact Lens Dropout
Several straightforward, high-return actions by eye care practices have the potential to increase retention rates among new contact lens wearers, according to consumer data from the Contact Lens Institute (CLI). The association is previewing its latest research during this week’s Vision Expo West conference in Las Vegas, part of its multi-year See Tomorrow initiative. CLI’s nationwide survey revealed that new (<2 years) and long-term (≥2 years) soft contact lens users share many similarities regarding factors that influence their decision to continue wear. Yet there are several differences that doctors and staff can lean into to help maintain satisfaction among more recently fit patients. This is particularly important when prior studies have shown that one in four wearers may drop out in the first year alone. “Broadly speaking, we found that new wearers benefit from more personalized care to meet their lifestyle needs, more attention from the entire practice team, and more encouragement and training,” said Stan Rogaski, CLI’s executive director. “That translates into happy, healthy patients whose satisfaction ratings skyrocket once they cross the two-year mark, turning them into lifelong contact lens fans.” A remarkable 86% of long-term contact lens patients characterized their overall satisfaction as high (8-10 on a 10-point scale), with 67% of new wearers stating the same. Among the long-term group, overall dissatisfaction was nearly non-existent, with a scant 2% providing a rating of 4 or less. When asked about doctor and staff actions to promote continued wear, contact lens patients identified three as most influential. They included making sure that contact lens prescriptions are updated to adapt to lifestyle changes (69% new wearers, 57% long-term wearers), providing trial lenses for new prescriptions (69% new wearers, 66% long-term wearers), and making sure people understand contact lens care (67% new wearers, 51% long-term wearers). While previous CLI See Tomorrow research has illustrated the importance of engaging the entire practice staff in patient communication, the latest data reinforces the essential nature of taking an all-hands approach. Among long-term wearers, 59% say that their eye doctor extremely or greatly influences the decision to keep using contact lenses, with 52% reporting the same for their optician, 35% for exam staff technicians, 25% for optical staff, and 21% for administrative staff. Notably, these percentages soar for new wearers by double digits—74% for their eye doctor, 64% for the optician, 53% for exam staff, 53% for optical staff, and 44% for administrators such as receptionists. Wearers also say the greater amount of time spent with the doctor and exam staff increases trust in their recommendations. This is more prominent among new wearers (74%), although still prevalent with long-term wearers (57%). The median opinion of what constituted “adequate” total exam time is 16-20 minutes for both groups. - Vision Expo West Events On Thursday, September 19, at 10 a.m. PT, three CLI Visionaries—eye care professionals who exemplify outstanding contact lens prescribing practices—will discuss the preliminary research findings and implications on the Vision Expo West Innovation Stage. “Disrupting the Dropout Dilemma: Bold Moves to Keep Consumers in Contact Lenses” panelists include Jennifer Seymour Brusven, LDO, NCLE-AC, ABO-AC, Yesnick Vision Center; Janelle Davison, OD, Brilliant Eyes Vision Center; and Shalu Pal, OD, FAAO, FSLS, FBCLA, FIAOMC, Dr. Shalu Pal & Associates. CLI Chairperson Carla Mack, OD, FAAO, Dipl AAO, FBCLA, will moderate. And after resoundingly positive feedback from their temporary transformation at Vision Expo East, the Bad Habits—the “EyeDocs of Rock”—will once again become the Good Habits during the Vision Expo East opening night event. With one iconic song, the group will put contact lens wearer retention center stage in a way that will have attendees singing along for days afterward. Showgoers can present their badge for admission at Brooklyn Bowl at The Linq Promenade, beginning at 9 p.m. PT. “After spending the past several months discussing how the eye care community can attract new contact lens wearers, we’re excited to turn everyone’s attention to keeping current wearers enthusiastic. The data we’ll share at Vision Expo West is only a fraction of what’s to come in our comprehensive research report later this year,” said Rogaski. The new research was commissioned by the Contact Lens Institute and conducted by Prodege from August 9-21, 2024, via an online survey. Respondents were U.S. residents ages 18-64 who reported wearing soft contact lenses at least once per week, inclusive of new wearers (n=200) and long-term wearers (n=201). The Contact Lens Institute advances the latest innovations in safe and effective contact lens and lens care products and services that provide unique benefits to patients while satisfying the evolving needs of eye care professionals. CLI undertakes activities that properly assess, enhance, promote, and balance contact lens and lens care industry welfare and growth, including the safe use of products in the marketplace. Its members include Alcon, Bausch + Lomb, CooperVision, and Johnson & Johnson Vision. For more information, visit contactlensinstitute.org
-
Myopia Action Month Returns, Uniting ECPs Worldwide this September
Myopia Profile has announced the return of Myopia Action Month this September (MyopiaAction.com). The initiative unites eye care professionals (ECPs) globally to address the rising prevalence of childhood myopia by taking decisive action against the epidemic. The program, enhanced based on inaugural year feedback, features four weeks of free online seminars, expert-led lectures, and educational resources, all focused on advancing myopia management as the standard of care. “Myopia Action Month was a tremendous success in 2023, and we’re even more excited for year two with the introduction of considerable new content,” said Dr. Kate Gifford, co-founder of Myopia Profile. “The latest offerings provide essential tools and resources that empower ECPs to take meaningful action in protecting the long-term eye health of children.” Throughout September, evidence-based educational materials, practice tools, and online resources will be available to ECPs, ensuring that learning is both relevant and directly applicable to clinical practice. New programming and highlights include: Online Seminar Series: Available on-demand from September 9, two learning streams cater to ECPs at different stages of their myopia management journey. The Foundations Seminar provides insights into research, efficacy, and defining success, while the Advanced Seminar for more experienced ECPs explores new technologies and strategies to enhance practice. ‘Made Simple’ Course Bundle: Myopia Profile’s new suite of ‘Made Simple’ Foundation Courses will be offered at special bundle pricing throughout September, providing comprehensive learning at a significant discount compared to purchasing individual courses. Practice Resource and Team Training: The world-first Myopia Management for the Practice Team certification course empowers practice managers, optical assistants, dispensers and trainees to answer parent questions and upskill, with a microlearning format designed to suit busy days. The new My Kids Vision survey practice tool and training opportunities can be accessed through Myopia Practice Accounts. The global initiative aligns with the World Council of Optometry’s advocacy for myopia patient care and is fully supported by Myopia Profile’s visionary sponsors including CooperVision, EssilorLuxottica, HOYA, OCULUS, Johnson & Johnson Vision, Menicon, Ocumetra, Alcon, Topcon Healthcare Europe, SightGlass Vision, Inc., and Visioneering Technologies, Inc. For more information on Myopia Action Month, including how to access the Online Seminar Series, visit www.myopiaaction.com
-
CLI Teams with Football Broadcaster Gene Steratore for Healthy Contact Lens Wear
Former professional football referee and current television rules analyst Gene Steratore is teaming with the Contact Lens Institute™ (CLI) to promote healthy contact lens wear and care. In a new video timed to the start of football season, the well-known broadcaster encourages eye care professionals to use The EASY Way when speaking with soft contact lens patients. The video will appear on major social media platforms over the next month and is available on YouTube at https://youtu.be/TBtZSFMVVb4. “For your contact lens patients, following a few rules and instructions helps them achieve healthy and comfortable wear and care. But take it from me… people can’t always follow what they don’t understand,” says Steratore, who is a familiar face and voice in millions of homes on fall and winter weekends. “That’s why the Contact Lens Institute introduced The EASY Way—three simple steps to improve their experience. For a guy whose life has been built around rules, there are few guidelines simpler than this.” Steratore was a professional football referee from 2003 to 2018 and a Division 1 college basketball referee from 1997 to 2018. Following his retirement from both, he has been a prominent game day rules authority for a major U.S. broadcasting network. His spot joins the recently produced “EASY as 1-2-3” video series that features eighteen prominent members of the eye care community calling on their colleagues to adopt the approach. Now in its fourth year, The EASY Way (Eyes, Awareness, Safety and You) is used by eye care practices across the U.S., Canada, and worldwide. It includes simplified tips, attention-grabbing infographics, and companion digital resources for use in practices, presented in a memorable and straightforward way. All components are available for free download within The EASY Way resource page on ContactLensInstitute.org. At the center of the program are three easy steps: 1. Think Clean. Wash and dry your hands every time before touching your lenses or eyes. If you wear reusable lenses, always clean and disinfect them with each removal, and clean your lens case as directed. Keep your lenses and case away from any type of water, which can contain harmful microorganisms. 2. Remember Fresher is Better. Wear your contacts for only as long as your eye care professional says, replacing them with fresh lenses on schedule. Only wear daily disposable lenses once, and always rely on new solution for reusable lens disinfection and storage. Replace your lens case at least every three months. 3. Trust Your Eye Doctor. Listen to your eye care professional, who has specialized training. If you have any questions, contact their office—they care about your health and great vision. The Contact Lens Institute advances the latest innovations in safe and effective contact lens and lens care products and services that provide unique benefits to patients while satisfying the evolving needs of eye care professionals. CLI undertakes activities that properly assess, enhance, promote and balance contact lens and lens care industry welfare and growth, including the safe use of products in the marketplace. Its members include Alcon, Bausch + Lomb, CooperVision, and Johnson & Johnson Vision. For more information, visit contactlensinstitute.org
-
New CORE Publication Provides Guidance on Cosmetics and Ocular Health
In response to the rising visibility of beauty trends on Internet and social media, the Centre for Ocular Research & Education (CORE) has dedicated Issue 79 of Contact Lens Update to the effect of cosmetics and cosmetic treatments on the eye. The publication is available at no charge by visiting ContactLensUpdate.com. “The popularity of social media platforms, like TikTok and Instagram, means that beauty products are promoted to a worldwide audience like never before. Positive product reviews or the recommendation of a beauty influencer spread like wildfire. However, most people often do not consider how their cosmetic choices could negatively impact their eyes before clicking ‘Add to Cart’,” said Jill Woods, Head of Clinical Research at CORE. “We further elevate our role as eye care practitioners when educating our patients about how different cosmetics or procedures impact their eyes. Having different treatment options to manage problems and offering alternative options helps ensure optimal eye health.” Claudine Courey, an optometrist in private practice and professional at an optometrist/ophthalmology speciality clinic in Quebec, Canada, authors the issue’s editorial. The overview discusses cosmetic products and procedures that practitioners encounter daily, delving into eyelash extensions and serums, tattooing the eyelid to mimic eyeliner, and the use of retinoids to improve facial skin appearance. She also discusses ocular complications and provides practical advice on the best way to manage and counsel patients. Dr. Courey also lends her expertise to this issue’s clinical insight column. The downloadable practitioner handout provides helpful tips to start conversations that address the effect of cosmetics on ocular health. It also offers communications methods that elevate patient understanding and compliance. The feature article is authored by Alison Ng, an independent optometric consultant and adjunct associate professor at the School of Optometry & Vision Science, University of Waterloo. She summarizes the findings of a study that investigated the prevalence of dry eye symptoms in a group of adult females from Saudi Arabia that use eye cosmetics. The overview explores the frequency and type of products that were applied, and the severity of the symptoms assessed with a validated dry eye questionnaire. The conference highlight is contributed by Mahsa Raeisi Ardali, an optometrist in Ontario, Canada. The American Academy of Optometry-presented case report discusses someone who underwent keratopigmentation (eye tattooing) to permanently change their eye color. Her piece details the dry eye management routine that was proposed and outlines different applications and complications associated with the procedure. Published six times per year, Contact Lens Update provides a global platform for unbiased clinical insights based in current research. Since 2011, each issue has provided dependable and up-to-date ocular health information for more than 60,000 leading eye care professionals. In addition to a complete archive of back issues, ContactLensUpdate.com offers a resource library that provides no-cost professional tools, patient resources, images and video. It also houses complimentary technical training videos produced by International Association of Contact Lens Educators, plus an industry glossary. Industry professionals can access the latest issue directly from ContactLensUpdate.com or quickly sign up for email receipt of future issues. The publication receives support from the educational arms of CooperVision and Johnson & Johnson Vision.
-
Myopia Profile Launches 'Made Simple' Courses to Empower ECPs with Practical Myopia Management
Myopia Profile today announced the launch of its new suite of ‘Made Simple’ Foundation Courses, specifically designed to empower eye care professionals (ECPs) with practical insights and step-by-step guidance in myopia management. These one-hour courses are built for ECPs seeking to quickly integrate evidence-based practices into their clinical routines and cover critical aspects of myopia management including clinical communication, long-term management strategies, and practical application through case studies and diverse knowledge checks. "After receiving positive feedback following the first ‘Made Simple’ course that launched last year, we are excited to release additional materials to further equip ECPs with the core knowledge needed to confidently begin and develop in their myopia management journey,” said Dr. Kate Gifford, co-founder of Myopia Profile. “These new courses were developed based on ECP feedback and provide concise, actionable insights backed by the latest research, ensuring that practitioners can apply what they learn directly in their practice." The new suite of Made Simple courses includes: Myopia Management is a practical, evidence-based course offering step-by-step clinical guidance, effective communication strategies, and an understanding of myopia control treatments and prescribing decisions. Visual Environment in Myopia provides ECPs with the knowledge to identify risk factors and understand the influence that outdoor time, near work, and screen time has on myopia, with guidance on clinical recommendations. Spectacles for Myopia Management gives insight into the new designs, efficacy, visual outcomes, and prescribing decisions for myopia control spectacles. Soft Contact Lenses for Myopia Management shares the latest design insights, prescribing tips, clinical action steps and communication strategies for soft myopia control contact lenses. Atropine for Myopia Management is a practical guide on the concentrations, combinations, safety, prescribing pathways, communication strategies, and long-term management of atropine for myopia control. Orthokeratology for Myopia Management has essential insights on ortho-k candidates, lens design, topography basics, candidates, combination with atropine, and practical steps across the fitting journey for successful myopia correction and control. The first course in the series is available at no cost, and Myopia Profile offers an option for “Course Bundle” pricing, providing comprehensive learning at a 40% saving compared to purchasing individual courses. Participants can also choose to enroll in courses individually. The platform offers accessibility pricing for colleagues in lower-income countries, automatically applied at checkout. The first four courses have received CPD (Continuing Professional Development) approval in the UK and Australia, with North American COPE (Council on Optometric Practitioner Education) accreditation currently in progress. For more information about the 'Made Simple' Foundation Courses and to enroll, visit Portal.MyopiaProfile.com
-
CooperVision Leads Myopia Control Dialogue: Bridging Optometry and Ophthalmology
CooperVision's leadership in advancing myopia control and establishing it as the standard of care in ocular health was prominently featured at the recent World Congress of Paediatric Ophthalmology and Strabismus (WCPOS V) in Kuala Lumpur, Malaysia. Continuing this momentum, CooperVision will also be showcased at the upcoming World Ophthalmology Congress (WOC) in Vancouver, Canada. These engagements underscore the company’s commitment to fostering collaboration between ophthalmology and optometry professionals worldwide. “Ophthalmology and the optometry communities are equally pivotal in driving adoption and standards of care, uncovering critical insights, and shaping the future of myopia control and management—endeavors we are honored to support and enhance,” said Elizabeth Lumb, BSc (Hons) MCOptom, FIACLE, FBCLA, Director of Global Professional Affairs, Myopia Management, CooperVision. “Leveraging both communities is crucial for developing a unified approach to myopia management, which can lead to reaching more patients with aligned treatment approaches.” During WCPOS V, CooperVision hosted the 2024 APAC Luminary Event, successfully bridging ophthalmology and optometry through an active roundtable discussion aimed at creating an industry white paper. Eye care professionals (ECPs) from both professions contributed insights to the forthcoming publication, "Joint Consensus on Standardizing Clinical Use of Contact Lenses for Myopia Management Across Ophthalmology and Optometry." In addition, CooperVision engaged both professions by presenting the results of its MiSight® 1 day seven-year clinical study. Professor Nicola Logan, Principal Investigator of the MiSight® 1 day clinical trial at Aston University, shared these insights along with findings from a separate investigator-initiated study at the company’s sponsored lunch symposium. Additionally, five scientific posters provided further evidence-based perspectives and practical strategies for managing myopia progression in children. Later this summer, CooperVision will sponsor the International Medical Contact Lens Council (IMCLC) Symposium to be held at WOC on August 16. The event, “Innovation in Contact Lens Use,” will convene global ophthalmology experts to discuss CooperVision’s advancements in myopia control. It will also underscore IMCLC’s dedication to worldwide education and information dissemination on contact lens-related topics for providers. “Our involvement in these conferences demonstrates CooperVision's unwavering commitment to the ophthalmology community and highlights our dedication to advancing the understanding and management of childhood myopia through evidence-based strategies,” said Lumb. “By spotlighting groundbreaking advancements in myopia control, CooperVision is facilitating meaningful dialogue and driving collective action within both fields, addressing the urgent need for a coordinated strategy to tackle the growing challenge of myopia.” For more information on these two events, visit wcposv2024.org and icowoc.org
-
Second Annual Myopia Action Month Set for September 2024
Following a successful inaugural year, Myopia Profile today announced the return of Myopia Action Month in September 2024. This global event is poised to deliver 30 days of tailored education, industry collaboration, and encouragement to empower eye care professionals (ECPs) to more effectively address the disease, helping counter growing prevalence rates. The global initiative aligns with the World Council of Optometry’s advocacy for myopia patient care and is fully supported by Myopia Profile’s visionary sponsors. “When we launched Myopia Action Month last year, feedback from the eye care community and industry was essential in shaping the curriculum,” said Dr. Kate Gifford, co-founder of Myopia Profile. “Heading into the second year, we’re expanding upon a successful foundation. The 2024 edition will bring even more engaging content and practical learning experiences.” This year’s program features two educational tracks, “Foundations” and “Advanced,” each offering an on-demand package of four 15-minute recorded lectures covering a variety of topics. Sponsor product videos will accompany Myopia Profile’s science-based lectures to support practical understanding. Additionally, expanded social media activities will encourage ECPs to post, share, and discuss Myopia Action Month, while new and existing resources will further support ECPs in refining their myopia management strategies. “The resources we’re developing are designed to empower ECPs at any stage to refine their myopia action plans and management strategies,” said Dr. Gifford. “Our 2024 event will introduce new practice support, online courses, downloadable resources, and a host of other additions. We had a fantastic first year, and we’re committed to making this September even more valuable in turning myopia knowledge and awareness into action.” More information about Myopia Action Month, including how to register at no cost, will be published on myopiaprofile.com in the coming months.
-
Latest CORE Publication Offers Soft Toric Contact Lens Insights for Practitioners
Prescribing soft toric contact lenses is center stage for Issue 78 of Contact Lens Update. Left uncorrected when eye care providers instead prescribe spherical soft lenses, astigmatism can lead to reduced visual acuity, visual fatigue, poor overall vision quality, and dropout. Published by the Centre for Ocular Research & Education (CORE), the bi-monthly publication is available at no charge by visiting ContactLensUpdate.com “The benefits of prescribing toric soft contact lenses for low to moderate astigmatism are important to consider, given that 45% of our patients have 0.75 D or more of refractive astigmatism, and 35% have 1.00 D or more,” said Daddi Fadel, DOptom, FSLS, FBCLA, FAAO, FIACLE, a clinical scientist at CORE. “The inability to tolerate the visual disturbances caused by residual astigmatism is a major reason why many patients abandon soft contact lenses. Recognizing the advantages and surmounting obstacles like visual performance, comfort, cost, and chair time are essential for patients' well-being. When assessing the cost-effectiveness of soft toric lenses compared to spherical ones in astigmatic individuals, practitioners should note that toric lenses provide significant advantages, often surpassing wearers' expectations despite the increased cost. Prescribing toric soft contact lenses for low and moderate astigmatism should become a standard practice.” Philip Morgan is professor of Optometry, head of Optometry, deputy head of the Division of Pharmacy and Optometry, and director of Eurolens Research at The University of Manchester. His editorial highlights evidence that indicates some patients who could benefit from toric soft contact lenses are not receiving appropriate fitting. Additionally, his piece debunks conceived barriers such as poor visual performance, reduced comfort, and increased cost and chair time. Dr. Melissa Barnett is the director of Optometry at the University of California, Davis, and globally recognized expert in specialty and scleral lenses, dry eye disease, keratoconus, and presbyopia. She authors the feature article examining the willingness to pay for soft toric lenses versus spherical contact lenses in individuals with astigmatism, shedding light on consumers' perceived value of the attributes of these lenses. Doerte Luensmann, a senior clinical scientist at the Centre for Ocular Research and Education, is involved in clinical trial management for multisite studies conducted in Canada and worldwide to support the development of study designs and management of clinical sites. Her clinical insight presents a case report illustrating the ineffectiveness of spherical lenses in correcting corneal astigmatism, emphasizing the significance of prescribing toric soft contact lenses for even low levels of astigmatism. The conference highlight is shared by Micheal Read, the new technologies manager at Eurolens Research, The University of Manchester, where he liaises with the contact lens industry and manages clinical and laboratory research projects. His poster presents the findings of their study on the visual effectiveness of soft toric contact lenses in cases of mild to moderate astigmatism. In addition to a complete archive of back issues, ContactLensUpdate.com offers a resource library that provides no-cost professional tools, patient resources, images and video. It also houses complimentary technical training videos produced by International Association of Contact Lens Educators, plus an industry glossary. Industry professionals can access the latest issue directly from ContactLensUpdate.com or quickly sign up for email receipt of future issues. The publication receives support from the educational arms of Alcon, CooperVision, and Johnson & Johnson Vision.
-
Avalue to Showcase Cutting-edge Smart Healthcare Solutions at Japan's International Modern Hospital Show 2024
Avalue Technology Inc. (TAIEX: 3479-TW), a global leader in industrial computer solutions, will participate in the International Modern Hospital Show (IMHS) in Tokyo, Japan, from July 10 to 12, 2024. Avalue will showcase a range of innovative solutions designed for smart healthcare, emphasizing our commitment to streamlining healthcare workflows and providing smarter solutions that drive the future of the healthcare industry. At this exhibition, Avalue will present the following highlight products: l Patient Information Solutions with Over-bed Vitals Sensor: The Over-bed Vitals Sensor, integrated into the SmartCaring T60, improves patient care in hospitals and long-term care facilities. Offering contactless monitoring, this solution ensures safety by utilizing millimeter wave and thermal sensors to track vital signs, including breathing, heart rate, temperature, and activity. l High-Performance Computing and Motherboards for High-End Medical Devices: Designed to meet the compute-intensive demands of industrial workloads, Avalue's HPC solutions enable organizations to harness the potential of artificial intelligence for data analytics, machine learning, and process optimization. l Real-Time Location System (RTLS) Solution: This advanced RTLS solution offers unparalleled insight into operations with its advanced RTLS capabilities, enabling real-time tracking of assets and personnel with indoor positioning accuracy within 30 centimeters. l Bedside Infotainment System: Enhance the patient experience and provide them with access to a range of entertainment options and useful information during their hospital stay. l ePaper Signs and Note Pad: Eco-friendly and easy-to-update digital paper solutions includes 25” digital signage and 10" HannsNote 2 Pad for ePaper signs and handheld note pad. These solutions are designed to keep patients informed and involved in their healthcare journey, prioritizing communication throughout the care process. l Medical Panel PC: Experience the pinnacle of medical computing with our Intel Processor Medical Panel PCs. Engineered for healthcare, our Medical Panel PCs boast advanced features, including front IP65 medical displays, ensuring optimal performance and reliability. l Telehealth System: Provides efficient and convenient telemedicine services, enabling patients to receive professional medical care at home or remote area. l Accelerated Osteoporosis Screening Solution: This AI solution uses advanced deep learning technology and digital X-ray flat-panel sensors to quickly assess osteoporosis risk, delivering recommendations within just 6 seconds. This provides a cost-effective, time-efficient, and highly accurate approach for bone density assessment. Avalue looks forward to meeting with attendees at IMHS 24. To explore these innovative smart hospital solutions, please visit Avalue and its partners at Booth #215. See you there. International Modern Hospital Show 2024 Information: l Date: 10-12 July, 2024 l Venue: Tokyo Big Sight, Tokyo, Japan l Booth No.: 215 l Show Information: https://www.noma-hs.com/
-
Overcoming Children’s Eye Health Obstacles @ IAPB’s 2030 In Sight Live
The next several weeks are packed with events and announcements, plus we are headed into summer holidays in the Northern Hemisphere. With so much happening, I wanted to make sure that one gathering did not go unnoticed. CooperVision’s Stuart Cockerill, a myopia management pioneer and leader of the company’s myopia management lifecycle team, will be part of a blue ribbon panel exploring how to prioritize children’s eye care on national and global agendas. Scheduled for Thursday, June 27, at 3:15 pm CST, 2030 In Sight for our Children is part of the International Agency for the Prevention of Blindness 2030 In Sight Live conference, taking place in Mexico City and virtually via livestream. Joining Stuart will be representatives from the India Vision Institute, the Fred Hollows Foundation, Queens University Belfast, Renovatio, the Global Partnership for Assistive Technology, and IAPB. You can read more about the conference, view the entire program, and register at https://www.iapb.org/learn/our-events/2030-in-sight-live-mexico/
-
World Council of Optometry and Alcon Extend Global Partnership for Dry Eye Disease Education
The World Council of Optometry (WCO) and Alcon are extending their education initiative to advance global, evidence-based dry eye disease education, which has garnered widespread exposure and interest over the past two years. Dry eye disease is a chronic, painful condition that impacts 1.4 billion people worldwide,[1] with reports of increased occurrence aligning with notable factors such as increasing use of technology, environmental triggers, and an aging population.[2] As part of the renewed collaboration, an update to the existing WCO Alcon Dry Eye Wheel is now available. This practical tool is designed to raise optometrists’ understanding of dry eye disease diagnosis and practical management. Now expanded to include content surrounding diet / dietary supplements, in-office and complex treatments, the latest version provides multifaceted, evidence-based knowledge that can be used in nearly all eye care environments. A dedicated website at dryeye.worldcouncilofoptometry.info includes a series of dry eye webinars recorded with world-renowned opinion leaders and also provides a robust collection of resources that can be used in clinical and educational settings. WCO President Sandra Block, O.D., M. Ed., MPH, FAAO, FCOV, said, “Extending our partnership with Alcon supports the education of optometrists globally about practical measures to better address dry eye, a condition that, without proper diagnosis and treatment, can lead to ocular surface disease. This year, we are planning more collaboration with university educators to increase access to the WCO Alcon Dry Eye Wheel and related educational resources for future generations of eye care professionals.” “We are all becoming more aware of the growing incidence and impact of dry eye on our patients. Within the last year, we have seen publications further clarifying some of the issues contributing to this rise¾from digital device use to social and environmental factors,” said Carla Mack, OD, MBA, FAAO, FBCLA, Head, Global and U.S. Professional Education and Development for Alcon. “We are proud to extend our ongoing partnership with the World Council of Optometry, reinforcing our commitment to helping make dry eye more understandable for both eye care professionals and patients. The ultimate goal is to empower optometrists to engage in conversations about this multi-factorial condition and educate on management options for their patients experiencing dry eye symptoms.” More information on the updated version of the WCO Alcon Dry Eye Wheel and other activities planned for the second year of the partnership will be posted to www.worldcouncilofoptometry.info and to the initiative’s dedicated website at dryeye.worldcouncilofoptometry.info ### [1] MarketScope (2020) 2020 Dry Eye Products Market Report. A Global Analysis for 2019 to 2025. October 2020. [2] Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K et al. (2017) TFOS DEWS II Epidemiology Report. Ocul Surf 15 (3): 334-365.
-
SightGlass Vision DOT Data Affirms Myopia Management Performance
Myopia management innovator SightGlass Vision will present new data surrounding its Diffusion Optics Technology™ (DOT 0.2) spectacle lenses from four studies at the ARVO 2024 Annual Meeting, which will draw thousands of eye and vision scientists to Seattle from May 5-9. The collective scientific body of knowledge deepens support for DOT™ spectacle lenses’ efficacy, safety, mechanism of action, and positive patient experience. The company’s flagship myopia control intervention uses thousands of light scattering elements to mimic more natural contrast on the retina—a unique mechanism of action to slow myopia progression in children. Building on its long-term CYPRESS trial, SightGlass Vision initiated CATHAY—a two-year, randomized, controlled clinical trial of children ages 6 to 13 across five sites in China. Control of Myopia Using Diffusion Optics Technology (DOT) Spectacle Lenses in a Chinese Population (Laughton D, et al) analyzes 71 participants at the six-month mark, indicating that DOT lenses substantially slowed myopia progression, as measured by cycloplegic spherical equivalent refraction (cSER) and axial length (AL), compared to the standard single vision spectacle lens control group. AL increased from baseline by 0.19 mm (p <0.001) in the control compared to -0.05 mm (p=0.04) among DOT lens wearers. cSER increased from baseline by -0.38D (p<0.0001) among the control versus by 0.01D (p=0.85) with the DOT group. Unadjusted mean differences in the changes from baseline were significant: -0.23 mm for AL and 0.39D for cSER. “The CATHAY interim results further validate the findings from our multi-year CYPRESS study, supporting the hypothesis that modulating retinal contrast can slow myopia progression in children from diverse populations,” said Debbie Laughton, BSc, PhD, Director of Medical Affairs for SightGlass Vision. Short Term Effect of DOT Spectacle Lenses on Choroidal Thickness in Emmetropic Children (Jabeen A, et al) illustrates the macula choroidal thickening (ChT) in children following short-term DOT spectacle lens wear, similar or greater to response from +3.00D spectacle lens use—a positive indication that contrast reduction favorably affects this uveal tract tissue. Conducted by the Centre for Ocular Research & Education (CORE), the research enrolled 30 children ages 8 to 14 in a two-visit, prospective, randomized, subject-masked crossover study. Treatment Zone Visual Acuity with Myopia Control Spectacle Lenses (Rani R, et al) profiles the immediate effect of Diffusion Optics Technology (DOT), Defocus Incorporated Multiple Segments (DIMS), and Highly Aspherical Lenslets (HAL) interventions on high- and low-contrast foveal visual acuity (VA). Investigators from Aston University’s Optometry & Vision Science Research Group enrolled 20 myopia adults in the prospective, single-visit, double-blind, four-way randomized crossover study to compare the technologies to single vision plano spectacle lenses. All three myopia management technologies performed well against the single vision lens, with DOT lenses providing superior VA in the peripheral treatment zone. Aston researchers are also presenting findings from The Short-Term Effects of Spectacle-Based Myopia Management Interventions on Dynamic Vision (Davis L, et al), which used the same group of participants. Dynamic vision when wearing DOT, DIMS, or HAL spectacle lenses was noted as good and generally similar to the single vision control. “Our scientific program at ARVO 2024 adds to the substantial evidence supporting the myopia control efficacy of Diffusion Optics Technology, as well as guiding eye care professionals on making more informed choices regarding spectacle lens interventions. We are enthusiastic about how DOT lenses have been received in multiple countries and remain excited by the prospect of reaching even more children around the world,” said Andrew Sedgwick, CEO of SightGlass Vision. SightGlass Vision’s patent-protected technology with clinically proven efficacy[1],[2],[3],[4] has made its commercial debut in several markets, including China, the Netherlands, and Israel, as well as through preliminary market trials in other countries. The company operates as a joint venture of CooperCompanies and EssilorLuxottica. For more information, visit SightGlassVision.com ### [1] Chalberg T., et al. Control of Myopia Using Diffusion Optics Spectacle Lenses: Efficacy and Safety Study (CYPRESS) 42-month results. ARVO 2023 Annual Meeting presentation. 27 April 2023. [2] Control of myopia using Diffusion Optics Technology™ spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS). British Journal of Ophthalmology Published Online First: 01 September 2022. DOI: 10.1136/bjo-2021-321005 [3] Rappon J., et al. Two-year effectiveness of a novel myopia management spectacle lens with full-time WEARERS. Invest. Ophthalmol. Vis. Sci. 2022;63(7):408. [4] Laughton, D et al. Safety and Efficacy of a Novel Spectacle Lens for Myopia Control Over Three Years. 2022 American Academy of Optometry annual meeting. 27 Oct 2022.
